Background: The Tilburg Pregnancy Distress Scale (TPDS) was developed to measure pregnancy-specific psychological distress among pregnant women.
Method: The present study evaluated the psychometric properties of the TPDS in a South African location. Analysis was conducted using data obtained from a sample of 205 participants (average age = 27.69 years [SD = 5.977], average gestation weeks = 25.37 weeks [SD = 8.448]; domicile = 63% rural) attending their antenatal check-ups at various medical health facilities in the Capricorn District, Limpopo Province. The analysis involved structural and convergent validation.
Results: Fit indices showed that the three-factor, second-order solution fitted the data better. The reliability estimates of the main TPDS factors, partner involvement (PI) and negative affect (NA), were good, and were obviously not influenced by gravidity. The associations of the TPDS factors with the Patient Health Questionnaire (PHQ-4) Depression and Anxiety, the Edinburgh Postnatal Depression Scale (EPDS), and the Pregnancy-Related Anxiety Scale (PRAS) were not generally good.
Conclusion: The results suggest that in spite of the TPDS having potential to be used in South Africa, further validation studies are required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/02646838.2021.1934422 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study.
Hum Reprod
December 2024
Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Study Question: What are the reproductive outcomes of patients who cryopreserved oocytes or embryos in the context of fertility preservation in the Netherlands?
Summary Answer: This study shows that after a 10-year follow-up period, the utilization rate to attempt pregnancy using cryopreserved oocytes or embryos was 25.5% and the cumulative live birth rate after embryo transfer was 34.6% per patient.
Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.
J Cancer Surviv
October 2024
Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Purpose: This study aimed to examine the (age-specific) informational needs and support sources used by Adolescent and Young Adult (AYA) cancer survivors throughout their cancer trajectory and socio-demographic and clinical factors associated with most common AYA-related informational needs.
Methods: A cross-sectional questionnaire study was conducted among AYA cancer survivors (mean, 10.3 years after diagnosis, SD = 5.
Impact of COVID-19 mitigation measures on perinatal outcomes in the Netherlands.
Public Health
November 2024
Department of Obstetrics and Gynaecology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, the Netherlands; Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands; Division of Neonatology, Department of Neonatal and Paediatric Intensive Care, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Objective: Investigate the acute impact of COVID-19 mitigation measures implemented in March 2020 on a comprehensive range of perinatal outcomes.
Study Design: National registry-based quasi-experimental study.
Methods: We obtained data from the Dutch Perinatal Registry (2010-2020) which was linked to multiple population registries containing sociodemographic variables.
Cumulative live birth rate of a blastocyst versus cleavage stage embryo transfer policy during in vitro fertilisation in women with a good prognosis: multicentre randomised controlled trial.
BMJ
September 2024
Amsterdam UMC, location University of Amsterdam, Centre for Reproductive Medicine, Amsterdam, Netherlands.
Objectives: To evaluate whether embryo transfers at blastocyst stage improve the cumulative live birth rate after oocyte retrieval, including both fresh and frozen-thawed transfers, and whether the risk of obstetric and perinatal complications is increased compared with cleavage stage embryo transfers during in vitro fertilisation (IVF) treatment.
Design: Multicentre randomised controlled trial.
Setting: 21 hospitals and clinics in the Netherlands, 18 August 2018 to 17 December 2021.
EuMAR stakeholder engagement: an analysis of medically assisted reproduction (MAR) data collection practices in EU countries†.
Hum Reprod
November 2024
Reproductive Medicine Unit, SISMER, Bologna, Italy.
Article Synopsis
- The study investigated the current medically assisted reproduction (MAR) data collection systems across EU Member States and explored how they could contribute to a unified registry for the EuMAR project.
- Significant variations were found in data types, collection methods, and reporting requirements, indicating a need for standardized practices to improve MAR data collection across the EU.
- The cross-sectional study surveyed and interviewed participants from 26 EU countries, revealing that half have national MAR registries with cycle-by-cycle data, while others rely on aggregated data or have no registry at all.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!